Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1976-05-13
1978-09-12
Rosen, Sam
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424305, A61K 3119, A61K 31215
Patent
active
041138821
ABSTRACT:
There is disclosed a dry, stabilized oral pharmaceutical formulation containing a prostaglandin E group prepared from a lyophilized composition comprising a prostaglandin E group and at least a member selected from the group consisting of a thiol compound, dextrin, dextran, a lower alkyl cellulose, and a water-soluble salt of deoxycholic acid.
REFERENCES:
patent: 3952004 (1976-04-01), Monkhouse
Kawada Hiroitsu
Kawahara Shigemi
Murakami Masuo
Okazaki Kiyoshi
Sekino Jun
Rosen Sam
Yamanouchi Pharmaceutical Co. Ltd.
LandOfFree
Stabilized oral prostaglandin formulation and the process for th does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stabilized oral prostaglandin formulation and the process for th, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stabilized oral prostaglandin formulation and the process for th will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2384721